Scarica l'app Stockscreener
1.33
1.53%
0.02
Pre-mercato:
1.34
0.01
+0.75%
Precedente Chiudi:
$1.31
Aprire:
$1.29
Volume 24 ore:
134.24K
Relative Volume:
0.36
Capitalizzazione di mercato:
$75.24M
Reddito:
$3.67M
Utile/perdita netta:
$-13.83M
Rapporto P/E:
-4.75
EPS:
-0.28
Flusso di cassa netto:
$-10.79M
1 W Prestazione:
+3.10%
1M Prestazione:
-1.48%
6M Prestazione:
+111.11%
1 anno Prestazione:
+7.26%
Intervallo 1D:
$1.27
$1.33
Intervallo di 1 settimana:
$1.27
$1.39
Portata 52W:
$0.48
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
Nome
Icecure Medical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ICCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
1.33 | 75.24M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Icecure Medical Ltd Borsa (ICCM) Ultime notizie
IceCure Medical (NASDAQ:ICCM) Trading Down 4.4% – Time to Sell? - Defense World
Clinical Study: ProSense Shows Superior Patient Satisfaction vs Traditional Breast Cancer Therapy - StockTitan
IceCure Medical (ICCM) Moves to Buy: Rationale Behind the Upgrade - MSN
IceCure seeks Israeli regulatory approval for XSense cryoablation system - Yahoo
IceCure seeks Israel approval for XSense cryoablation system By Investing.com - Investing.com Australia
IceCure Medical Ltd. Submits Filing for Regulatory Approval of Its Next-Generation XSense? Cryoablation System in Israel - Marketscreener.com
IceCure seeks Israel approval for XSense cryoablation system - Investing.com
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel - PR Newswire
A stock that deserves closer examination: Icecure Medical Ltd (ICCM) - US Post News
IceCure Medical Ltd (NASDAQ:ICCM) Sees Significant Drop in Short Interest - Defense World
Short Interest in IceCure Medical Ltd (NASDAQ:ICCM) Decreases By 9.2% - MarketBeat
IceCure Medical Ltd's (NASDAQ:ICCM) Profit Outlook - Yahoo Finance
IceCure gets favorable FDA AdCom vote for ProSense System - MSN
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates - StreetInsider.com
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision - PR Newswire
IceCure Medical (NASDAQ:ICCM) Shares Down 1.6%Here's What Happened - MarketBeat
ICCMIceCure Medical Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod - MSN
IceCure submits application to China’s NMPA for cryoablation system approval - Yahoo! Voices
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China - The Malaysian Reserve
IceCure Medical (NASDAQ:ICCM) Stock Price Down 1.6% – Should You Sell? - Defense World
IceCure Medical Ltd. Files for Regulatory Approval of ProSense Cryoablation System in China - Marketscreener.com
Icecure Medical Announces Equity Distribution Agreement - TipRanks
IceCure Medical Reports Strong Growth and Anticipates FDA Approval in 2025 - TipRanks
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America - Longview News-Journal
Investors bid IceCure Medical (NASDAQ:ICCM) up US$14m despite increasing losses YoY, taking five-year CAGR to 43% - Simply Wall St
The five-year returns have been enviable for IceCure Medical (NASDAQ:ICCM) shareholders despite underlying losses increasing - Yahoo Finance
Financial Analysis: SANUWAVE Health (OTCMKTS:SNWV) versus IceCure Medical (NASDAQ:ICCM) - Defense World
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule - Kilgore News Herald
IceCure Medical regains full Nasdaq compliance - Medical Buyer
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minim - GuruFocus.com
IceCure Medical Regains Nasdaq Compliance, Securing Market Position - TipRanks
IceCure to Meet Institutional Investors at the H.C. Wainwright a - GuruFocus.com
IceCure Medical Regains Nasdaq Compliance, Secures Market Position After Meeting Price Requirements - StockTitan
IceCure earns European patent win for next-gen cryoablation tech - Mass Device
IceCure Medical Ltd. Receives an Intention to Grant Notice from the European Patent Office - Marketscreener.com
Icecure Nicks Up On European OK For Connector - MENAFN.COM
IceCure Nicks Up on European OK for Connector - Baystreet.ca
European Patent Office Issues Intention to Grant Notice to IceCu - GuruFocus.com
European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology - Marketscreener.com
IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference - GuruFocus.com
IceCure Medical appoints new board director - Investing.com India
IceCure Medical appoints new board director By Investing.com - Investing.com Australia
Icecure Medical Appoints New Board Director with Financial Expertise - TipRanks
IceCure Medical Ltd Appoints Li Haixiang as Director - Marketscreener.com
IceCure Medical (NASDAQ:ICCM) Stock Price Down 0.4%Here's Why - MarketBeat
IceCure Medical (NASDAQ:ICCM) Shares Down 0.4% – What’s Next? - Defense World
Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting - Marketscreener.com
IceCure Medical's ProSense Shows Breakthrough 5-Year Breast Cancer Treatment Results in Major Clinical Trial - StockTitan
Study Published in the British Journal of Radiology Demonstrates - GuruFocus.com
Icecure Medical Ltd Azioni (ICCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.08%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):